Patents Assigned to Vergell Medical S.A.
  • Patent number: 10426841
    Abstract: The present invention relates to a composition and a combination comprising at least one first drug and at least one protein-binding prodrug, wherein the protein-binding prodrug comprises a protein-binding group, a second drug, and a linker that can be cleaved hydrolytically, enzymatically, or in a pH-dependent manner in the body, as well as to a kit and a pharmaceutical composition comprising said composition or combination.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: October 1, 2019
    Assignee: Vergell Medical S.A.
    Inventor: Felix Kratz
  • Patent number: 10220101
    Abstract: The present invention relates to a composition and a combination comprising at least one first drug and at least one protein-binding prodrug, wherein the proteinbinding prodrug comprises a protein-binding group, a second drug, and a linker that can be cleaved hydrolytically, enzymatically, or in a pH-dependent manner in the body, as well as to a kit and a pharmaceutical composition comprising said composition or combination.
    Type: Grant
    Filed: April 13, 2011
    Date of Patent: March 5, 2019
    Assignee: Vergell Medical S.A.
    Inventor: Felix Kratz